Daniel Lynch, Director at bluebird bio, Inc. (BLUE), sold 4,000 shares at $108.29 ($436K) on 2017-06-23, disclosed to the SEC on 2017-06-27.
Open-market sale of $436k BLUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.29 | 2,200 | $238K | 54.6% |
| 2 | $109.74 | 1,000 | $110K | 25.1% |
| 3 | $110.48 | 800 | $88K | 20.3% |
| Total | $109.09 avg | 4,000 | $436K | 100% |
| Filing → |
| SWTX | SELL | 2025-02-12 | $15.4M | — | Filing → |
| BPMC | SELL | 2018-02-16 | $1.0M | — | Filing → |
| BPMC | SELL | 2018-02-14 | $2.6M | — | Filing → |